CTP-499

DRUG3 trials

Sponsors

Concert Pharmaceuticals

Conditions

Chronic Kidney DiseaseDiabetic NephropathyStage 3 Chronic Kidney DiseaseType 2 Diabetes Mellitus

Phase 1

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499

CompletedNCT01328821

Concert PharmaceuticalsDiabetic Nephropathy

Start: 2011-03-31End: 2011-06-30Updated: 2011-10-26

Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease

CompletedNCT01460199

Concert PharmaceuticalsStage 3 Chronic Kidney Disease

Start: 2011-08-31End: 2011-12-31Updated: 2013-05-24

Phase 2

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

CompletedNCT01487109

Concert PharmaceuticalsChronic Kidney Disease, Type 2 Diabetes Mellitus

Start: 2012-01-31End: 2015-01-31Updated: 2021-08-16